News

However, Brexit and competition from countries like USA, Germany and Japan are cited as reasons the UK can’t seem to hold its competitive edge globally.

The information makes it “impossible to see how the original target for 5,000 extra GPs could be met by 2020”.

The boom is thanks in part to a change in the funding landscape, expressed in a four-fold increase to £2.8 billion of investment in early-stage ventures.

Avion is set to fund a new international Phase III trial with costs up to $25 million.

As many as 3,200 women in England living with advanced HR+, HER2- breast cancer will now be eligible for the treatment.

A 10% increase in vaccination may be associated with as much as a 10% fall in sickness absence.

The CGT Catapult has released its latest Good Manufacturing Practice report and skills demand report.

Lack of sleep can induce flare-ups, creating a vicious cycle and putting patients at risk of serious additional health challenges.

The news comes shortly after a YouGov poll found that 81% of HCPs think that general analysis of data would help enable quicker diagnosis and more effective treatment.

Despite the majority of healthcare professionals thinking that general analysis of data would help enable quicker diagnosis, most don’t trust “big tech” companies to do it.

The treatment reduced haemoglobin A1c by 0.19% and LDL-C by 25% in those not on statin background therapy.

The gadolinium-enhanced MRI requirement in the previous NICE guidance was a “significant barrier” for many clinicians and their patients.

$1m of the funding will go in to AI and drug discovery resources per disease project.

The company intends to file a Marketing Authorisation Application (MAA) in the first half of next year, based on Phase II and III trials.